Fascin levels have been reported to be upregulated in more aggressive and metastatic cancers and fascin has been described as a significant and independent prognostic indicator of the outcome of non-small cell lung cancer [23, 56]. The gene discussed is FSCN1; the disease is metastatic malignant neoplasm.